Showing 9,561 - 9,580 results of 18,313 for search 'significant ((((teer decrease) OR (((a decrease) OR (greatest decrease))))) OR (mean decrease))', query time: 0.55s Refine Results
  1. 9561

    Data Sheet 1_Microbiota profiling from biopsied tissues in complex infections: a diagnostic and prognostic analysis through metagenomic next-generation sequencing.docx by Tiange Song (13878401)

    Published 2025
    “…Early mNGS sampling within 7 days after admission was associated with a significantly decreased risk of all-cause mortality (HR 0.18, 95% CI 0.04–0.94; P=0.04), treatment failure (OR 0.17, 95% CI 0.05–0.66; P=0.01), and increased probability of clinical resolution (OR 3.03, 95% CI 1.24–7.40; P=0.01).…”
  2. 9562

    Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

    Published 2024
    “…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”
  3. 9563

    Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

    Published 2024
    “…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”
  4. 9564

    Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

    Published 2024
    “…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”
  5. 9565

    Charge Delocalization for Electrically Detachable Poly(ionic liquids) Ionoadhesives with Ultrahigh Mechanical Robustness by Shijie Sun (9385097)

    Published 2024
    “…In addition, charge delocalization sharply decreases the escaping energy of mobile ions and thus significantly facilitates ion hopping. …”
  6. 9566
  7. 9567

    DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  8. 9568

    Descriptive statistics of the sample. by Alex Bawuah (21702688)

    Published 2025
    “…The lack of birthweight data is a significant challenge in monitoring the global prevalence of extreme birthweight, either low or high, and newborn health. …”
  9. 9569

    Sample size characteristics. by Alex Bawuah (21702688)

    Published 2025
    “…The lack of birthweight data is a significant challenge in monitoring the global prevalence of extreme birthweight, either low or high, and newborn health. …”
  10. 9570

    Data used for the Study. by Alex Bawuah (21702688)

    Published 2025
    “…The lack of birthweight data is a significant challenge in monitoring the global prevalence of extreme birthweight, either low or high, and newborn health. …”
  11. 9571

    Data_Sheet_1_Exercising educational equity using California’s physical fitness data: a call for more school physical fitness programs, data, and research.docx by Da’Shay Templeton (19802262)

    Published 2024
    “…The lack of safe and affordable options for physical activity coupled with the significant decrease in physical activity rates among most American children underscores the need for programs, data, and research on physical fitness in schools, where children spend a significant amount of their time. …”
  12. 9572

    Raw data set for figures in this study. by Lijun Wang (176511)

    Published 2024
    “…Recent discoveries have determined acetylation as a significant modification for CPS, although its impact on HMV and virulence was previously unknown. …”
  13. 9573

    Supplementary Material for: The effectiveness of Long-Term Continuation of Atezolizumab Plus Bevacizumab In Patients Who Receiving Systemic Chemotherapy For Advanced Hepatocellular... by figshare admin karger (2628495)

    Published 2025
    “…Results: According to the periods from the initiation of Atez/Bev to that of the second-line therapy, patients were classified into a long continuation group (Group-L, n = 19), ≥ 11 months; or a short continuation group (Group-S, n = 19), < 11 months. …”
  14. 9574

    Radiologic results of patients. by Han-Ting Shih (20880477)

    Published 2025
    “…</p><p>Conclusions</p><p>MUKA significantly corrects the majority of ankle alignment towards a more neutral position. …”
  15. 9575

    Anonymized data used for analysis. by Han-Ting Shih (20880477)

    Published 2025
    “…</p><p>Conclusions</p><p>MUKA significantly corrects the majority of ankle alignment towards a more neutral position. …”
  16. 9576

    Relationship of smoking cessation and NAFLD. by Hyun Joe (16612221)

    Published 2025
    “…Recent studies have demonstrated that cigarette smoking is a significant risk factor for the development of NAFLD. …”
  17. 9577

    Relationship of smoking and NAFLD. by Hyun Joe (16612221)

    Published 2025
    “…Recent studies have demonstrated that cigarette smoking is a significant risk factor for the development of NAFLD. …”
  18. 9578

    Data Sheet 1_Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis.docx by Ping Li (31981)

    Published 2025
    “…Finerenone resulted in a numerical decrease in the risk of the cardiovascular composite outcome (hazard ratio 0.91; 95% confidence interval 0.50–1.67) and a significantly reduced risk of the key secondary kidney outcome (hazard ratio 0.48; 95% confidence interval 0.29–0.79; p = 0.0029). …”
  19. 9579
  20. 9580

    Table 1_Therapeutic effects of traditional Chinese medicine Hua-Feng-Dan in a rat model of ischemic stroke involve renormalization of gut microbiota.xlsx by Xiaoxia He (459582)

    Published 2025
    “…<p>Hua-Feng-Dan is a traditional Chinese medicine used to treat ischemic stroke, but little is known about its therapeutic mechanism. …”